Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection (Q57160250)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

genetic variation

1 reference

based on heuristic

inferred from title

Francesco Marabita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mariagrazia Rumi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sergio Abrignani

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Raffaele De Francesco

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Stella De Nicola

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cristina Cheroni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rossana Scavelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Roberta Soffredini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Massimo Colombo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

19 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1127-1134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Hepatitis C pharmacogenetics: state of the art in 2010.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Progression of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Diagnosis and quantitation of fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Liver biopsy: The best, not the gold standard

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

21 January 2018

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24503

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24503

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21721028%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57160250&oldid=2139005892"